Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats
- PMID: 11159042
- DOI: 10.1165/ajrcmb.24.2.4264
Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats
Abstract
Respiratory syncytial virus (RSV) infection in adult rats causes exaggerated inflammation after sensory nerve stimulation in the extrapulmonary, but not in the intrapulmonary airways. The goal of this study was to analyze neurogenic inflammation in weanling F-344 rats infected with RSV 18 +/- 2 d after birth. Five days after RSV inoculation, the extravasation of Evans blue-labeled albumin after nerve stimulation was significantly greater in the intrapulmonary airways of RSV-infected weanling rats than in pathogen-free control rats. In contrast, no difference was found in the extrapulmonary airways. The level of messenger RNA (mRNA) encoding the substance P (SP) receptor (neurokinin 1 [NK1]) increased fourfold in RSV-infected lungs, whereas mRNA encoding the VIPR1 receptor for the antiinflammatory vasoactive intestinal peptide (VIP) increased to a much lesser degree. mRNAs encoding the other neurokinin (NK2) and VIP (VIPR2) receptors were not affected by the virus. Selective inhibition of the NK1 receptor abolished neurogenic inflammation in RSV-infected intrapulmonary airways. Also, neurogenic inflammation and NK1 receptor upregulation in infected lungs were inhibited by prophylaxis with a monoclonal antibody against RSV. These data suggest that RSV lower respiratory tract infection makes the intrapulmonary airways of young rats abnormally susceptible to the proinflammatory effects of SP by selectively upregulating the expression of NK1 receptors.
Similar articles
-
Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats.Pediatr Res. 2004 Apr;55(4):657-65. doi: 10.1203/01.PDR.0000112244.72924.26. Epub 2004 Jan 7. Pediatr Res. 2004. PMID: 14711892
-
Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S66-74; discussion S74-5. doi: 10.1097/01.inf.0000053888.67311.1d. Pediatr Infect Dis J. 2003. PMID: 12671455 Review.
-
Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus.Am J Physiol Lung Cell Mol Physiol. 2002 May;282(5):L1143-50. doi: 10.1152/ajplung.00323.2001. Am J Physiol Lung Cell Mol Physiol. 2002. PMID: 11943681
-
Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs.Am J Physiol. 1999 Oct;277(4):L831-40. doi: 10.1152/ajplung.1999.277.4.L831. Am J Physiol. 1999. PMID: 10516226
-
Neurogenic inflammation. A model for studying efferent actions of sensory nerves.Adv Exp Med Biol. 1996;410:453-62. Adv Exp Med Biol. 1996. PMID: 9030340 Review.
Cited by
-
Is There an Association between Viral Infections and Risk for Pediatric Obstructive Sleep Apnea? A Systematic Review.Children (Basel). 2023 Mar 2;10(3):487. doi: 10.3390/children10030487. Children (Basel). 2023. PMID: 36980046 Free PMC article. Review.
-
Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19.Auton Neurosci. 2022 Jan;237:102903. doi: 10.1016/j.autneu.2021.102903. Epub 2021 Nov 10. Auton Neurosci. 2022. PMID: 34894589 Free PMC article. Review.
-
Small Non-coding RNA Expression Following Respiratory Syncytial Virus or Measles Virus Infection of Neuronal Cells.Front Microbiol. 2021 Sep 3;12:671852. doi: 10.3389/fmicb.2021.671852. eCollection 2021. Front Microbiol. 2021. PMID: 34539595 Free PMC article.
-
In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach.Eur J Pharm Sci. 2021 May 1;160:105771. doi: 10.1016/j.ejps.2021.105771. Epub 2021 Feb 19. Eur J Pharm Sci. 2021. PMID: 33617948 Free PMC article.
-
Emerging Therapeutic Modalities against COVID-19.Pharmaceuticals (Basel). 2020 Aug 8;13(8):188. doi: 10.3390/ph13080188. Pharmaceuticals (Basel). 2020. PMID: 32784499 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
